Management strategies for a better outcome in unstable coronary artery disease (Q40858772)

24 September 2017

1 reference

title

Management strategies for a better outcome in unstable coronary artery disease (English)

1 reference

24 September 2017

2

L Wallentin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

8

C Bode

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

author name string

R W Campbell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

F W Verheugt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

A G Turpie

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

A Maseri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

W Klein

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

J G Cleland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

R Becker

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

J Anderson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

M E Bertrand

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

C R Conti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

publication date

1 May 1998

1 reference

24 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

page(s)

314-322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

Insights into the pathogenesis of acute ischemic syndromes

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210504

Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210504

Alterations of coagulation and fibrinolytic and kallikrein-kinin systems in the acute and postacute phases in patients with unstable angina pectoris.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210504

The role of calcium antagonists in ischaemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210504

Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions

21 January 2018

1 reference

12 December 2020

Predictors of risk in patients with unstable angina admitted to a district general hospital

1 reference

12 December 2020

Reactivation of unstable angina after the discontinuation of heparin

1 reference

12 December 2020

Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group

1 reference

12 December 2020

Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group

1 reference

12 December 2020

Rapid thrombus dissolution by continuous infusion of urokinase through an intracoronary perfusion wire prior to and following PTCA: results in native coronaries and patent saphenous vein grafts

1 reference

12 December 2020

Early exercise testing after coronary care for suspected unstable coronary artery disease--safety and diagnostic value

1 reference

12 December 2020

1 reference

12 December 2020

Aspirin, heparin, or both to treat acute unstable angina

1 reference

12 December 2020

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

1 reference

12 December 2020

Silent ischemia predicts infarction and death during 2 year follow-up of unstable angina

1 reference

12 December 2020

Coronary arteriographic findings soon after non-Q-wave myocardial infarction

1 reference

12 December 2020

Sensitivity of routine clinical criteria for diagnosing myocardial infarction within 24 hours of hospitalization

1 reference

12 December 2020

Coronary bypass surgery for unstable angina

1 reference

12 December 2020

Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials

1 reference

12 December 2020

Prognosis of patients > or = 70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients > or = 70 years of age with Q-wave acute myocardial infarction

1 reference

12 December 2020

Relation of severity of symptoms to transient myocardial ischemia and prognosis in unstable angina

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

Efficacy of adjunctive thrombolytic therapy in percutaneous transluminal coronary angioplasty

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Persistent activation of coagulation mechanism in unstable angina and myocardial infarction

1 reference

12 December 2020

Adjunctive thrombolytic therapy during angioplasty for ischemic rest angina. Results of the TAUSA Trial. TAUSA Investigators. Thrombolysis and Angioplasty in Unstable Angina trial

1 reference

12 December 2020

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

12 December 2020

Relationship between hemostatic abnormalities and neuroendocrine activity in heart failure

1 reference

12 December 2020

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia

1 reference

12 December 2020

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial

1 reference

12 December 2020

Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction

1 reference

12 December 2020

Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group

1 reference

12 December 2020

Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)

1 reference

12 December 2020

Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis

1 reference

12 December 2020

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

12 December 2020

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

12 December 2020

ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

Restoration of coronary flow in myocardial infarction by intravenous chimeric 7E3 antibody without exogenous plasminogen activators. Observations in animals and humans

1 reference

12 December 2020

Risk stratification in unstable coronary artery disease. Additive value of troponin T determinations and pre-discharge exercise tests. FRISK Study Group

1 reference

12 December 2020

Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study

1 reference

12 December 2020

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

12 December 2020

Validation of a clinical prediction rule for left ventricular ejection fraction after myocardial infarction in patients > or = 65 years old.

1 reference

12 December 2020

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

12 December 2020

"Rescue" utilization of abciximab for the dissolution of coronary thrombus developing as a complication of coronary angioplasty

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960210504

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.4960210504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655264&resulttype=core&format=json

15 May 2020

9595213

1 reference